Amedeo Smart

Free Medical Literature Service

 

Amedeo

Vaccines
  Free Subscription

Articles published in
JAMA
    April 2024
  1. ANDERER S
    Could "Empathetic Refutation" Help Clinicians Sway Vaccine Skeptics?
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.4493.
    >> Share

  2. HARRIS E
    Measles Outbreaks in US and Abroad Prompt CDC Vaccination Alert.
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5153.
    >> Share

  3. HARRIS E
    COVID-19 Vaccination Linked With Lower Risk of Cardiac Problems.
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5152.
    >> Share

  4. HARRIS E
    Safety Concerns Put a Stop to Maternal RSV Vaccine Study.
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5155.
    >> Share

    March 2024
  5. EDWARDS KM, Griffin MR
    Postmarketing Vaccine Safety Assessments: Important Work in Progress.
    JAMA. 2024;331:915-917.
    >> Share

  6. LU Y, Matuska K, Nadimpalli G, Ma Y, et al
    Stroke Risk After COVID-19 Bivalent Vaccination Among US Older Adults.
    JAMA. 2024;331:938-950.
    >> Share

  7. HARRIS E
    WHO Issues First Recommendations for Managing Diphtheria.
    JAMA. 2024;331:907.
    >> Share

  8. ANDERER S
    CDC Recommends Additional COVID-19 Booster for Older Adults.
    JAMA. 2024 Mar 13. doi: 10.1001/jama.2024.2071.
    >> Share

  9. HARRIS E
    HPV Vaccination Rates Stagnated During COVID-19 Pandemic.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1569.
    >> Share

    February 2024
  10. ANDERSSON NW, Thiesson EM, Hviid A
    Adverse Events After XBB.1.5-Containing COVID-19 mRNA Vaccines.
    JAMA. 2024 Feb 26:e241036. doi: 10.1001/jama.2024.1036.
    >> Share

  11. JAMIESON KH, Johnson KB, Cappola AR
    Misinformation and the Vaccine Adverse Event Reporting System.
    JAMA. 2024 Feb 26. doi: 10.1001/jama.2024.1757.
    >> Share

  12. HARRIS E
    New Prevention Guidance for Antibiotic-Resistant Meningococcal Cases.
    JAMA. 2024 Feb 21. doi: 10.1001/jama.2024.0731.
    >> Share

  13. HARRIS E
    Africa's First Routine Malaria Vaccination Campaign Begins.
    JAMA. 2024 Feb 7. doi: 10.1001/jama.2024.0170.
    >> Share

  14. NORMAN M, Magnus MC, Soderling J, Juliusson PB, et al
    Neonatal Outcomes After COVID-19 Vaccination in Pregnancy.
    JAMA. 2024;331:396-407.
    >> Share

  15. FELDSTEIN LR, Britton A, Grant L, Wiegand R, et al
    Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years.
    JAMA. 2024;331:408-416.
    >> Share

    January 2024
  16. HARRIS E
    Missed Vaccine Doses Tied to Worse COVID-19 Outcomes.
    JAMA. 2024 Jan 31. doi: 10.1001/jama.2023.28340.
    >> Share

  17. HARRIS E
    CDC Warns of Low Vaccination Rates Amid Spike in Respiratory Diseases.
    JAMA. 2024 Jan 17. doi: 10.1001/jama.2023.27428.
    >> Share

  18. MARKS P, Califf R
    Is Vaccination Approaching a Dangerous Tipping Point?
    JAMA. 2024 Jan 5. doi: 10.1001/jama.2023.27685.
    >> Share

  19. HARRIS E
    High-Dose Flu Vaccine May Be More Effective for Midlife Adults.
    JAMA. 2024 Jan 3. doi: 10.1001/jama.2023.26114.
    >> Share

    December 2023
  20. RUBIN R
    Despite Safe and Effective Vaccine, Measles Cases and Deaths Increased Worldwide From 2021 to 2022.
    JAMA. 2023 Dec 20. doi: 10.1001/jama.2023.25527.
    >> Share

  21. RUBIN R
    Up the Nose and Down the Windpipe May Be the Path to New and Improved COVID-19 Vaccines.
    JAMA. 2023 Dec 6. doi: 10.1001/jama.2023.0644.
    >> Share

    November 2023
  22. HARRIS E
    FDA Approves First Chikungunya Vaccine.
    JAMA. 2023 Nov 29. doi: 10.1001/jama.2023.23505.
    >> Share

  23. HARRIS E
    Measles Outbreaks Grow Amid Declining Vaccination Rates.
    JAMA. 2023 Nov 29. doi: 10.1001/jama.2023.23511.
    >> Share

  24. HARRIS E
    Live-Virus Shingles Vaccine Provided Some Long-Term Protection.
    JAMA. 2023 Nov 29. doi: 10.1001/jama.2023.23507.
    >> Share

  25. STEWART TG, Rebolledo PA, Mourad A, Lindsell CJ, et al
    Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical Trial.
    JAMA. 2023 Nov 17:e2323363. doi: 10.1001/jama.2023.23363.
    >> Share

  26. HARRIS E
    Combined COVID-19, Flu Vaccine Candidate Headed to Phase 3 Trials.
    JAMA. 2023 Nov 15. doi: 10.1001/jama.2023.22353.
    >> Share

  27. HARRIS E
    FDA Will Evaluate First Self-Administered FluMist Vaccine.
    JAMA. 2023 Nov 8. doi: 10.1001/jama.2023.21870.
    >> Share

  28. MALANI P
    Highlights From IDWeek 2023-New Vaccines, Artificial Intelligence, and Antimicrobial Resistance.
    JAMA. 2023 Nov 8. doi: 10.1001/jama.2023.19291.
    >> Share

    October 2023
  29. HARRIS E
    Vaccination Hesitancy Increasing Among Pregnant Women.
    JAMA. 2023 Oct 18. doi: 10.1001/jama.2023.19800.
    >> Share

  30. HARRIS E
    Trial Launches of New HIV Vaccine Candidate With CMV Vector.
    JAMA. 2023 Oct 4. doi: 10.1001/jama.2023.19203.
    >> Share

  31. DELAMATER PL, Buttenheim AM, Salmon DA, Schwartz JL, et al
    Kindergarten Vaccination Status in California After Changes to Medical Exemption Policy.
    JAMA. 2023 Oct 2:e2316995. doi: 10.1001/jama.2023.16995.
    >> Share

    September 2023
  32. HARRIS E
    NIH Launches Phase 1 Trial of Broader "Universal" Flu Vaccine.
    JAMA. 2023 Sep 27. doi: 10.1001/jama.2023.18741.
    >> Share

  33. HARRIS E
    Southern Hemisphere Outcomes Support Flu Vaccine Effectiveness.
    JAMA. 2023 Sep 20. doi: 10.1001/jama.2023.17822.
    >> Share

  34. RUBIN R
    Updated COVID-19 Vaccine Now Available in US, Recommended for Everyone Older Than 6 Months.
    JAMA. 2023 Sep 18. doi: 10.1001/jama.2023.19759.
    >> Share

  35. TARTOF SY, Frankland TB, Slezak JM, Puzniak L, et al
    Receipt of BNT162b2 Vaccine and COVID-19 Ambulatory Visits in US Children Younger Than 5 Years.
    JAMA. 2023 Sep 15. doi: 10.1001/jama.2023.17473.
    >> Share

  36. HARRIS E
    HHS To Invest $1.4 Billion in New COVID-19 Vaccines, Therapies.
    JAMA. 2023 Sep 6. doi: 10.1001/jama.2023.16678.
    >> Share

  37. HARRIS E
    CDC Recommends RSV Immunization for Infants.
    JAMA. 2023;330:797.
    >> Share

    August 2023
  38. HARRIS E
    FDA Approves Maternal RSV Vaccine.
    JAMA. 2023 Aug 30. doi: 10.1001/jama.2023.16106.
    >> Share

    July 2023
  39. HARRIS E
    Free COVID-19 Vaccinations on the Way for Uninsured Adults.
    JAMA. 2023 Jul 26. doi: 10.1001/jama.2023.13133.
    >> Share

  40. GOSTIN LO, Reiss D, Mello MM
    Vaccination Mandates-An Old Public Health Tool Faces New Challenges.
    JAMA. 2023 Jul 24. doi: 10.1001/jama.2023.11059.
    >> Share

  41. HARRIS E
    First Ever Malaria Vaccine to Be Distributed in Africa.
    JAMA. 2023 Jul 19. doi: 10.1001/jama.2023.12549.
    >> Share

  42. HARRIS E
    CDC: RSV Vaccine Recommended for Older People.
    JAMA. 2023 Jul 12. doi: 10.1001/jama.2023.12537.
    >> Share

  43. RUBIN R
    This Fall's COVID-19 Vaccines Will Target Omicron XBB Subvariants, but Who Needs Them Remains to Be Seen.
    JAMA. 2023 Jul 5. doi: 10.1001/jama.2023.10053.
    >> Share

    June 2023
  44. HARRIS E
    Amid Paraguay Chikungunya Outbreak, Vaccine Candidate Safe, Immunogenic.
    JAMA. 2023 Jun 21. doi: 10.1001/jama.2023.10738.
    >> Share


  45. Public Health: An Interesting Parliamentary Debate on Vaccination.
    JAMA. 2023;329:2099.
    >> Share

  46. ANDREWS N, Stowe J, Miller E, Ramsay M, et al
    BA.1 Bivalent COVID-19 Vaccine Use and Stroke in England.
    JAMA. 2023 Jun 15. doi: 10.1001/jama.2023.10123.
    >> Share

  47. HARRIS E
    Hybrid COVID-19 Immunity Common by Fall of 2022.
    JAMA. 2023 Jun 14. doi: 10.1001/jama.2023.10399.
    >> Share

  48. DESAI AN, Malani PN
    JYNNEOS Vaccine for Mpox.
    JAMA. 2023;329:1995.
    >> Share

    May 2023
  49. HARRIS E
    COVID-19 Vaccine and Health Care Visits for Menstrual Changes.
    JAMA. 2023 May 17. doi: 10.1001/jama.2023.8658.
    >> Share

  50. HARRIS E
    FDA Clears RSV Vaccine for Adults Aged 60 Years or Older.
    JAMA. 2023 May 17. doi: 10.1001/jama.2023.8657.
    >> Share

  51. DENG L, Lopez LK, Glover C, Cashman P, et al
    Short-term Adverse Events Following Immunization With Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) Vaccine for Mpox.
    JAMA. 2023 May 5. doi: 10.1001/jama.2023.7683.
    >> Share

  52. HARRIS E
    BCG Vaccine Not Effective Against COVID-19.
    JAMA. 2023 May 3. doi: 10.1001/jama.2023.7763.
    >> Share

    April 2023
  53. HARRIS E
    FDA Simplifies COVID-19 Vaccination, Permits Some Additional Doses.
    JAMA. 2023 Apr 26. doi: 10.1001/jama.2023.6624.
    >> Share

  54. HARRIS E
    How Parents' Views Are Tied to Children's COVID-19 Vaccination.
    JAMA. 2023 Apr 19. doi: 10.1001/jama.2023.6292.
    >> Share

  55. HARRIS E
    RSV Vaccine, Monoclonal Antibody Safe, Effective in Phase 3 Trials.
    JAMA. 2023 Apr 12. doi: 10.1001/jama.2023.6254.
    >> Share

  56. HARRIS E
    Updated WHO Guidance for Prioritizing COVID-19 Vaccines.
    JAMA. 2023 Apr 12. doi: 10.1001/jama.2023.6256.
    >> Share

  57. AMMIRATI E, Moslehi JJ
    Diagnosis and Treatment of Acute Myocarditis: A Review.
    JAMA. 2023;329:1098-1113.
    >> Share

    March 2023
  58. ZHOU YB
    Human Mpox Virus Infection After Receipt of Modified Vaccinia Ankara Vaccine.
    JAMA. 2023;329:1031.
    >> Share

  59. HAZRA A, Schneider JA
    Human Mpox Virus Infection After Receipt of Modified Vaccinia Ankara Vaccine-Reply.
    JAMA. 2023;329:1032.
    >> Share

  60. HARRIS E
    Cost-effective Global Strep B Vaccination Would Prevent Infant Deaths.
    JAMA. 2023 Mar 22. doi: 10.1001/jama.2023.4005.
    >> Share

  61. SURAN M
    Physicians Say an Idaho House Bill That Would Criminalize Administering mRNA Vaccines Is an Attack on the Medical Profession-Even If It Doesn't Become Law.
    JAMA. 2023 Mar 15. doi: 10.1001/jama.2023.3401.
    >> Share

  62. SO S, Terrault N, Conners EE
    Universal Adult Hepatitis B Screening and Vaccination as the Path to Elimination.
    JAMA. 2023 Mar 10. doi: 10.1001/jama.2023.2806.
    >> Share

    February 2023
  63. FLANNERY DD, Zevallos Barboza A, Wade KC, Pfeifer MR, et al
    Measles Serostatus Among Parturient Patients at 2 Philadelphia Hospitals in 2021.
    JAMA. 2023;329:682-684.
    >> Share

  64. HARRIS E
    COVID-19 Vaccination During Pregnancy Protected Infants.
    JAMA. 2023 Feb 22. doi: 10.1001/jama.2023.2098.
    >> Share

  65. NAGGIE S, Boulware DR, Lindsell CJ, Stewart TG, et al
    Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial.
    JAMA. 2023 Feb 20:e231650. doi: 10.1001/jama.2023.1650.
    >> Share

  66. HARRIS E
    Marburg Vaccine Safe, Immunogenic in Phase 1 Trial.
    JAMA. 2023 Feb 15. doi: 10.1001/jama.2023.1343.
    >> Share

  67. RUBIN R
    Questions Remain About What SARS-CoV-2 Variants Should Go Into the Annual COVID-19 Vaccines Proposed by the FDA.
    JAMA. 2023 Feb 15. doi: 10.1001/jama.2022.22285.
    >> Share

  68. CHU WM, Wang CY, Wei JC
    Vaccination, Acute Myocardial Infarction, and Ischemic Stroke After COVID-19 Infection.
    JAMA. 2023;329:426.
    >> Share

  69. HUH K, Kim YE, Jung J
    Vaccination, Acute Myocardial Infarction, and Ischemic Stroke After COVID-19 Infection-Reply.
    JAMA. 2023;329:426-427.
    >> Share

  70. SURAN M
    New HIV Vaccine Approach Safely Stimulated Rare Precursors to Broadly Neutralizing Antibodies.
    JAMA. 2023 Feb 1. doi: 10.1001/jama.2022.23242.
    >> Share

  71. LARKIN H
    Hybrid Immunity More Protective Than Prior SARS-CoV-2 Infection Alone.
    JAMA. 2023 Feb 1. doi: 10.1001/jama.2023.0743.
    >> Share

    January 2023
  72. ROLFES MA, Talbot HK, McLean HQ, Stockwell MS, et al
    Household Transmission of Influenza A Viruses in 2021-2022.
    JAMA. 2023 Jan 26. doi: 10.1001/jama.2023.0064.
    >> Share

  73. RUBIN R
    Large Cohort Study Finds Possible Association Between Postural Orthostatic Tachycardia Syndrome and COVID-19 Vaccination but Far Stronger Link With SARS-CoV-2 Infection.
    JAMA. 2023 Jan 25. doi: 10.1001/jama.2023.0050.
    >> Share

  74. SLOMSKI A
    Ebola Vaccines Safe and Immunogenic in 2 Trials.
    JAMA. 2023;329:278-279.
    >> Share

  75. SLOMSKI A
    Novel Oral Polio Vaccine Safely Induces Antibodies Among Vaccine-Naive Infants.
    JAMA. 2023;329:279.
    >> Share

  76. MCCARTHY MW, Naggie S, Boulware DR, Lindsell CJ, et al
    Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
    JAMA. 2023 Jan 12. doi: 10.1001/jama.2022.24100.
    >> Share

  77. LARKIN H, Larkin H
    Twenty-Strain "Universal" mRNA Flu Vaccine Effective in Animal Studies.
    JAMA. 2023;329:114.
    >> Share

  78. LARKIN H
    Whole-Sporozoite Malaria Vaccine Candidate Shows Real-world Promise.
    JAMA. 2023;329:115.
    >> Share

    December 2022
  79. SLOMSKI A
    Moderna COVID-19 Vaccine Safe and Effective for Children 6 Months to 5 Years.
    JAMA. 2022;328:2388.
    >> Share

  80. LARKIN H
    WHO: Vaccine Market Report Highlights Inequitable Global Distribution.
    JAMA. 2022;328:2294.
    >> Share

  81. WALTER K, Malani PN
    What Is Measles?
    JAMA. 2022;328:2370.
    >> Share

  82. ABBASI J
    Amid Ohio Measles Outbreak, New Global Report Warns of Decreased Vaccination During COVID-19 Pandemic.
    JAMA. 2022 Dec 15. doi: 10.1001/jama.2022.23241.
    >> Share

  83. LARKIN H
    Investigational RSV Vaccine Given During Pregnancy Protects Newborns.
    JAMA. 2022;328:2201.
    >> Share

  84. MARKS PW, Gruppuso PA, Adashi EY
    Urgent Need for Next-Generation COVID-19 Vaccines.
    JAMA. 2022 Dec 9. doi: 10.1001/jama.2022.22759.
    >> Share

  85. LARKIN HD
    Novavax COVID-19 Vaccine Booster Authorized.
    JAMA. 2022;328:2101.
    >> Share

  86. MANMADHAN A, Ahuja T
    Association Between COVID-19 Booster Vaccination and Omicron Infection in a Cohort of Players and Staff in the National Basketball Association.
    JAMA. 2022;328:2164-2165.
    >> Share

  87. MACK CD, Anderson DJ, DiFiori J
    Association Between COVID-19 Booster Vaccination and Omicron Infection in a Cohort of Players and Staff in the National Basketball Association-Reply.
    JAMA. 2022;328:2165.
    >> Share

    November 2022
  88. SLOMSKI A
    Intranasal COVID-19 Vaccine Disappointing in First-in-Human Trial.
    JAMA. 2022;328:2003.
    >> Share

  89. KUEHN BM
    Targeted Flu Vaccination Campaigns Needed for Certain Racial and Ethnic Groups.
    JAMA. 2022;328:2005.
    >> Share

  90. RUBIN R
    Vaccine Approved in Pregnancy to Protect Young Infants.
    JAMA. 2022;328:1898.
    >> Share

  91. LARKIN HD
    WHO Backs Single Dose of Hepatitis A Vaccine in Some Cases.
    JAMA. 2022;328:1896.
    >> Share

  92. LARKIN HD
    Studies Find Single Dose of HPV Vaccines May Be Effective.
    JAMA. 2022;328:1896.
    >> Share

  93. KUEHN BM
    Shifting Hepatitis A Epidemiology Requires Renewed Vaccination Efforts.
    JAMA. 2022;328:1800.
    >> Share

  94. KUEHN BM
    Single Monkeypox Vaccine Dose Provides Some Protection.
    JAMA. 2022;328:1801.
    >> Share

  95. KUEHN BM
    Second COVID-19 Booster Increases Protection for Nursing Home Patients.
    JAMA. 2022;328:1800-1801.
    >> Share

    October 2022
  96. NAGGIE S, Boulware DR, Lindsell CJ, Stewart TG, et al
    Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
    JAMA. 2022 Oct 21. pii: 2797483. doi: 10.1001/jama.2022.18590.
    >> Share

  97. THOMPSON MG, Yoon SK, Naleway AL, Meece J, et al
    Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers.
    JAMA. 2022;328:1523-1533.
    >> Share

  98. BELLANDI D
    Rotavirus Leads Global Diarrhea Hospitalizations Among Young Children.
    JAMA. 2022;328:1490.
    >> Share

  99. LARKIN HD
    Progress on Replication-Defective Live Virus Vaccines.
    JAMA. 2022;328:1387.
    >> Share

  100. KUEHN BM
    Catch-up Vaccinations Needed for Some Adolescents.
    JAMA. 2022;328:1389-1390.
    >> Share

  101. ABBASI J
    White House Advisor Nahid Bhadelia, MD, MALD, on COVID-19 in Resource-Limited Nations-Undercounted Deaths, Vaccine Inequity, and More.
    JAMA. 2022 Oct 5. pii: 2797281. doi: 10.1001/jama.2022.13663.
    >> Share

    September 2022
  102. HAZRA A, Rusie L, Hedberg T, Schneider JA, et al
    Human Monkeypox Virus Infection in the Immediate Period After Receiving Modified Vaccinia Ankara Vaccine.
    JAMA. 2022 Sep 30. pii: 2797135. doi: 10.1001/jama.2022.18320.
    >> Share

  103. KELLY JD, Leonard S, Hoggatt KJ, Boscardin WJ, et al
    Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines.
    JAMA. 2022 Sep 26. pii: 2796892. doi: 10.1001/jama.2022.17985.
    >> Share

  104. TENFORDE MW, Link-Gelles R, Patel MM
    Long-term Protection Associated With COVID-19 Vaccination and Prior Infection.
    JAMA. 2022 Sep 26. pii: 2796894. doi: 10.1001/jama.2022.14660.
    >> Share

  105. LIN DY, Gu Y, Xu Y, Wheeler B, et al
    Association of Primary and Booster Vaccination and Prior Infection With SARS-CoV-2 Infection and Severe COVID-19 Outcomes.
    JAMA. 2022 Sep 26. pii: 2796893. doi: 10.1001/jama.2022.17876.
    >> Share

  106. RIDGWAY JP, Tideman S, French T, Wright B, et al
    Odds of Hospitalization for COVID-19 After 3 vs 2 Doses of mRNA COVID-19 Vaccine by Time Since Booster Dose.
    JAMA. 2022 Sep 23. pii: 2796847. doi: 10.1001/jama.2022.17811.
    >> Share

  107. RUBIN R
    The Dreaded "Twindemic" of Influenza and COVID-19 Has Not Yet Materialized-Might This Be the Year?
    JAMA. 2022 Sep 21. pii: 2796806. doi: 10.1001/jama.2022.15062.
    >> Share

  108. LARKIN HD
    Backslide in Global Childhood Vaccinations.
    JAMA. 2022;328:1029.
    >> Share

  109. LARKIN HD
    New Data on Heterologous COVID-19 Vaccine Combinations.
    JAMA. 2022;328:916-917.
    >> Share

  110. LARKIN HD
    FDA Authorizes Intradermal Vaccine, Streamlines Rules to Increase Monkeypox Treatment Access.
    JAMA. 2022;328:819.
    >> Share

  111. CULLEN JP, Russ S, Russell HA
    Theater for Vaccine Hesitancy-Setting the Stage for Difficult Conversations.
    JAMA. 2022 Sep 2. pii: 2796160. doi: 10.1001/jama.2022.14864.
    >> Share

    August 2022
  112. BARNETT ML, Waken RJ, Zheng J, Orav EJ, et al
    Changes in Health and Quality of Life in US Skilled Nursing Facilities by COVID-19 Exposure Status in 2020.
    JAMA. 2022 Aug 29. pii: 2795935. doi: 10.1001/jama.2022.15071.
    >> Share

  113. RUBIN R
    Despite Its Fan Base, Newly Authorized "Traditional" Novavax COVID-19 Vaccine Is Having Trouble Gaining a Foothold in the US.
    JAMA. 2022 Aug 24. pii: 2795814. doi: 10.1001/jama.2022.13661.
    >> Share

  114. LO RE V 3RD, Dutcher SK, Connolly JG, Perez-Vilar S, et al
    Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients.
    JAMA. 2022;328:637-651.
    >> Share

  115. LARKIN HD
    New "Universal" Flu Vaccine Candidate Enters Clinical Trial.
    JAMA. 2022;328:518.
    >> Share

  116. KUEHN BM
    More Effective Flu Vaccines Recommended for Older Adults.
    JAMA. 2022;328:519.
    >> Share

    July 2022
  117. KIM YE, Huh K, Park YJ, Peck KR, et al
    Association Between Vaccination and Acute Myocardial Infarction and Ischemic Stroke After COVID-19 Infection.
    JAMA. 2022 Jul 22. pii: 2794753. doi: 10.1001/jama.2022.12992.
    >> Share

  118. LARKIN HD
    Mix-and-Match COVID-19 Boosters After Inactivated Virus Vaccine.
    JAMA. 2022;328:234.
    >> Share

  119. KUEHN BM
    Newer Poxvirus Vaccine Is Recommended.
    JAMA. 2022;328:123.
    >> Share

  120. RUBIN R
    COVID-19 Boosters This Fall to Include Omicron Antigen, but Questions Remain About Its Value.
    JAMA. 2022 Jul 8. pii: 2794259. doi: 10.1001/jama.2022.11252.
    >> Share

  121. AZZOLINI E, Levi R, Sarti R, Pozzi C, et al
    Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers.
    JAMA. 2022 Jul 1. pii: 2794072. doi: 10.1001/jama.2022.11691.
    >> Share

    June 2022
  122. ABBASI J
    COVID-19 mRNA Vaccine Booster During Pregnancy Increases Maternal and Fetal Antibodies.
    JAMA. 2022 Jun 22. pii: 2793740. doi: 10.1001/jama.2022.11145.
    >> Share

  123. LARKIN HD
    mRNA COVID-19 Vaccine Booster After Inactivated Vaccine Primary Series.
    JAMA. 2022;327:2280.
    >> Share

  124. LARKIN HD
    Maternal RSV Vaccine Could Protect Infants, Interim Analysis Suggests.
    JAMA. 2022;327:2182.
    >> Share

  125. KATZ SE, Edwards K
    Protecting Children Against Omicron.
    JAMA. 2022;327:2195-2197.
    >> Share

  126. JONES JM, Opsomer JD, Stone M, Benoit T, et al
    Updated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Estimates Based on Blood Donations, July 2020-December 2021.
    JAMA. 2022 Jun 13. pii: 2793517. doi: 10.1001/jama.2022.9745.
    >> Share

  127. LI Y
    Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave.
    JAMA. 2022;327:2147-2148.
    >> Share

  128. TAI CG, Maragakis LL, Connolly S, DiFiori J, et al
    Association Between COVID-19 Booster Vaccination and Omicron Infection in a Highly Vaccinated Cohort of Players and Staff in the National Basketball Association.
    JAMA. 2022 Jun 2. pii: 2793169. doi: 10.1001/jama.2022.9479.
    >> Share

  129. RUBIN R
    Challenges of Deciding Whether and How to Update COVID-19 Vaccines to Protect Against Variants.
    JAMA. 2022 Jun 1. pii: 2793149. doi: 10.1001/jama.2022.9367.
    >> Share

    May 2022
  130. WEISS SR
    Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US.
    JAMA. 2022;327:2019-2020.
    >> Share

  131. OSTER ME, Shay DK, Shimabukuro TT
    Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US-Reply.
    JAMA. 2022;327:2020-2021.
    >> Share

  132. KUEHN BM
    Cardiac Complications More Common After COVID-19 Than Vaccination.
    JAMA. 2022;327:1951.
    >> Share

  133. FLEMING-DUTRA KE, Britton A, Shang N, Derado G, et al
    Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.
    JAMA. 2022 May 13. pii: 2792524. doi: 10.1001/jama.2022.7493.
    >> Share

  134. DORABAWILA V, Hoefer D, Bauer UE, Bassett MT, et al
    Risk of Infection and Hospitalization Among Vaccinated and Unvaccinated Children and Adolescents in New York After the Emergence of the Omicron Variant.
    JAMA. 2022 May 13. pii: 2792525. doi: 10.1001/jama.2022.7319.
    >> Share

  135. LARKIN HD
    Four Vaccine Doses Prevented Severe Omicron COVID-19 Better Than 3.
    JAMA. 2022;327:1748.
    >> Share

  136. LARKIN HD
    Two mRNA COVID-19 Vaccines Stimulate Different Immune Responses.
    JAMA. 2022;327:1748.
    >> Share

  137. KUEHN BM
    Age Range Is Expanded for Universal Hepatitis B Vaccination.
    JAMA. 2022;327:1749.
    >> Share

  138. KUEHN BM
    mRNA Booster Improves a COVID-19 Vaccine's Effectiveness.
    JAMA. 2022;327:1749.
    >> Share

  139. SLOMSKI A
    Studies Examine Risk of Hearing Loss After COVID-19 Vaccination.
    JAMA. 2022;327:1641.
    >> Share

  140. MARKS P, Woodcock J, Califf R
    COVID-19 Vaccination-Becoming Part of the New Normal.
    JAMA. 2022 May 2. pii: 2792030. doi: 10.1001/jama.2022.7469.
    >> Share

    April 2022
  141. KUEHN BM
    COVID-19 Vaccine Effectiveness in Youth Varies by Age, Variant.
    JAMA. 2022;327:1540.
    >> Share

  142. RAZZAGHI H, Meghani M, Crane B, Ellington S, et al
    Receipt of COVID-19 Booster Dose Among Fully Vaccinated Pregnant Individuals Aged 18 to 49 Years by Key Demographics.
    JAMA. 2022 Apr 22. pii: 2791659. doi: 10.1001/jama.2022.6834.
    >> Share

  143. LARKIN HD
    Fractionating COVID-19 Vaccine Doses May Save Lives.
    JAMA. 2022;327:1438.
    >> Share

  144. WOLFSON AR, Freeman EE, Blumenthal KG
    Urticaria 12 Days After COVID-19 mRNA Booster Vaccination.
    JAMA. 2022 Apr 14. pii: 2791317. doi: 10.1001/jama.2022.5247.
    >> Share

  145. ABBASI J
    Large US Study Examines First 6 Months of COVID-19 Vaccine Safety Data.
    JAMA. 2022;327:1323.
    >> Share

  146. ABBASI J
    Vaccine Booster Dose Appears to Reduce Omicron Hospitalizations.
    JAMA. 2022;327:1323.
    >> Share

  147. KUEHN BM
    Myocarditis Adverse Event Less Common After COVID-19 Vaccine Booster.
    JAMA. 2022;327:1324.
    >> Share

  148. SLOMSKI A
    Maternal COVID-19 Vaccine Safe for Infants.
    JAMA. 2022;327:1218.
    >> Share

  149. NISSEN SE, Wolski K, Balog C, Swerdlow DI, et al
    Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels.
    JAMA. 2022 Apr 3. pii: 2790912. doi: 10.1001/jama.2022.5050.
    >> Share

  150. NATTINO G, Castiglioni S, Cereda D, Della Valle PG, et al
    Association Between SARS-CoV-2 Viral Load in Wastewater and Reported Cases, Hospitalizations, and Vaccinations in Milan, March 2020 to November 2021.
    JAMA. 2022 Apr 1. pii: 2790911. doi: 10.1001/jama.2022.4908.
    >> Share

    March 2022
  151. BRUXVOORT K, Slezak J, Qian L, Sy LS, et al
    Association Between 2-Dose vs 3-Dose Hepatitis B Vaccine and Acute Myocardial Infarction.
    JAMA. 2022 Mar 25. pii: 2790492. doi: 10.1001/jama.2022.2540.
    >> Share

  152. KHARBANDA EO, Vazquez-Benitez G
    COVID-19 mRNA Vaccines During Pregnancy: New Evidence to Help Address Vaccine Hesitancy.
    JAMA. 2022 Mar 24. pii: 2790610. doi: 10.1001/jama.2022.2459.
    >> Share

  153. MAGNUS MC, Ortqvist AK, Dahlqwist E, Ljung R, et al
    Association of SARS-CoV-2 Vaccination During Pregnancy With Pregnancy Outcomes.
    JAMA. 2022 Mar 24. pii: 2790608. doi: 10.1001/jama.2022.3271.
    >> Share

  154. FELL DB, Dhinsa T, Alton GD, Torok E, et al
    Association of COVID-19 Vaccination in Pregnancy With Adverse Peripartum Outcomes.
    JAMA. 2022 Mar 24. pii: 2790607. doi: 10.1001/jama.2022.4255.
    >> Share

  155. SLOMSKI A
    Pneumococcal Vaccine Induces Immune Responses to 20 Serotypes.
    JAMA. 2022;327:1118.
    >> Share

  156. STEAD W
    One Person.
    JAMA. 2022;327:1131-1132.
    >> Share

  157. FRIEDENSOHN L, Levin D, Fadlon-Derai M, Gershovitz L, et al
    Myocarditis Following a Third BNT162b2 Vaccination Dose in Military Recruits in Israel.
    JAMA. 2022 Mar 17. pii: 2790421. doi: 10.1001/jama.2022.4425.
    >> Share

  158. ABBASI J
    First mRNA HIV Vaccine Clinical Trial Launches.
    JAMA. 2022;327:909.
    >> Share

  159. KUEHN BM
    Racial and Ethnic, Gender Disparities Seen in LGBT COVID-19 Vaccination Rates.
    JAMA. 2022;327:910.
    >> Share

    February 2022
  160. ABBASI J
    Widespread Misinformation About Infertility Continues to Create COVID-19 Vaccine Hesitancy.
    JAMA. 2022 Feb 22. pii: 2789477. doi: 10.1001/jama.2022.2404.
    >> Share

  161. KUEHN BM
    New COVID-19 Vaccine Aims to Increase Global Vaccine Access.
    JAMA. 2022;327:614.
    >> Share

  162. KUEHN BM
    COVID-19 Vaccines Safe, Effective in Rheumatic Diseases.
    JAMA. 2022;327:614.
    >> Share

  163. BRITTON A, Fleming-Dutra KE, Shang N, Smith ZR, et al
    Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance.
    JAMA. 2022 Feb 14. pii: 2789294. doi: 10.1001/jama.2022.2068.
    >> Share

  164. TAN SHX, Pung R, Wang LF, Lye DC, et al
    Association of Homologous and Heterologous Vaccine Boosters With COVID-19 Incidence and Severity in Singapore.
    JAMA. 2022 Feb 11. pii: 2789151. doi: 10.1001/jama.2022.1922.
    >> Share

  165. ABBASI J
    Fourth COVID-19 Vaccine Dose Increases Low Antibodies.
    JAMA. 2022;327:517.
    >> Share

  166. KUEHN BM
    Health Care Professionals' Advice Can Increase COVID-19 Vaccination.
    JAMA. 2022;327:518.
    >> Share

  167. SHOOK LL, Atyeo CG, Yonker LM, Fasano A, et al
    Durability of Anti-Spike Antibodies in Infants After Maternal COVID-19 Vaccination or Natural Infection.
    JAMA. 2022 Feb 7. pii: 2788986. doi: 10.1001/jama.2022.1206.
    >> Share

    January 2022
  168. SURAN M
    Coverage of COVID-19 Vaccine Counseling for Children and Youths.
    JAMA. 2022;327:313.
    >> Share

  169. LI HF, Hu SM, Lv M
    Association of Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barre Syndrome.
    JAMA. 2022;327:392-393.
    >> Share

  170. WOO EJ, Dimova RB, Mba-Jonas A
    Presumptive Guillain-Barre Syndrome Associated With Receipt of the Ad26.COV2.2.S COVID-19 Vaccine-Reply.
    JAMA. 2022;327:393-394.
    >> Share

  171. OSTER ME, Shay DK, Su JR, Gee J, et al
    Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.
    JAMA. 2022;327:331-340.
    >> Share

  172. KLOMPAS M, Karan A
    Preventing SARS-CoV-2 Transmission in Health Care Settings in the Context of the Omicron Variant.
    JAMA. 2022 Jan 24. pii: 2788503. doi: 10.1001/jama.2022.0262.
    >> Share

  173. ABBASI J, Rubin R, Suran M
    How the Supreme Court's COVID-19 Vaccine Mandate Rulings Could Shape the Pandemic's Next Phase.
    JAMA. 2022 Jan 21. pii: 2788486. doi: 10.1001/jama.2022.0791.
    >> Share

  174. OMER SB, Malani PN
    Booster Vaccination to Prevent COVID-19 in the Era of Omicron: An Effective Part of a Layered Public Health Approach.
    JAMA. 2022 Jan 21. pii: 2788487. doi: 10.1001/jama.2022.0892.
    >> Share

  175. GOSTIN LO, Parmet WE, Rosenbaum S
    The US Supreme Court's Rulings on Large Business and Health Care Worker Vaccine Mandates: Ramifications for the COVID-19 Response and the Future of Federal Public Health Protection.
    JAMA. 2022 Jan 21. pii: 2788481. doi: 10.1001/jama.2022.0852.
    >> Share

  176. ACCORSI EK, Britton A, Fleming-Dutra KE, Smith ZR, et al
    Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    JAMA. 2022 Jan 21. pii: 2788485. doi: 10.1001/jama.2022.0470.
    >> Share

  177. WANG L, Davis PB, Kaelber DC, Volkow ND, et al
    Comparison of mRNA-1273 and BNT162b2 Vaccines on Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Death During the Delta-Predominant Period.
    JAMA. 2022 Jan 20. pii: 2788408. doi: 10.1001/jama.2022.0210.
    >> Share

  178. KUEHN BM
    Vaccine Development Is Charting a New Path in Malaria Control.
    JAMA. 2022 Jan 19. pii: 2788387. doi: 10.1001/jama.2021.20627.
    >> Share

  179. KUEHN BM
    Vaccine Passports Help Boost Lagging Vaccination Rates.
    JAMA. 2022;327:209.
    >> Share

  180. ADASHI EY, Cohen IG
    The Pandemic Preparedness Program: Reimagining Public Health.
    JAMA. 2022;327:219-220.
    >> Share

  181. ABBASI J
    Former Biden-Harris Transition Advisors Propose a New National Strategy for COVID-19.
    JAMA. 2022 Jan 18. pii: 2788316. doi: 10.1001/jama.2022.0216.
    >> Share

  182. RUBIN R
    COVID-19 Vaccines Have Been Available in the US for More Than a Year-What's Been Learned and What's Next?
    JAMA. 2022 Jan 11. pii: 2788213. doi: 10.1001/jama.2022.0106.
    >> Share

  183. ABBASI J
    Studies Suggest COVID-19 Vaccine Boosters Save Lives.
    JAMA. 2022;327:115.
    >> Share

  184. ABBASI J
    Homing In On a SARS-CoV-2 Correlate of Protection.
    JAMA. 2022;327:115.
    >> Share

  185. ABBASI J
    COVID-19 Vaccine Focused on T-Cell Response Promising in Early Trial.
    JAMA. 2022;327:115.
    >> Share

  186. WALD A
    Booster Vaccination to Reduce SARS-CoV-2 Transmission and Infection.
    JAMA. 2022 Jan 10. pii: 2788105. doi: 10.1001/jama.2021.23726.
    >> Share

  187. SPITZER A, Angel Y, Marudi O, Zeltser D, et al
    Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.
    JAMA. 2022 Jan 10. pii: 2788104. doi: 10.1001/jama.2021.23641.
    >> Share

  188. BORIO LL, Bright RA, Emanuel EJ
    A National Strategy for COVID-19 Medical Countermeasures: Vaccines and Therapeutics.
    JAMA. 2022 Jan 6. pii: 2787946. doi: 10.1001/jama.2021.24165.
    >> Share

    December 2021
  189. ABBASI J
    RSV Vaccines, Finally Within Reach, Could Prevent Tens of Thousands of Yearly Deaths.
    JAMA. 2021 Dec 29. pii: 2787757. doi: 10.1001/jama.2021.23772.
    >> Share


  190. Two New Pneumococcal Vaccines-Prevnar 20 and Vaxneuvance.
    JAMA. 2021;326:2521-2522.
    >> Share

  191. SLOMSKI A
    More Pediatric Data for First Cell-Derived Influenza Vaccine.
    JAMA. 2021;326:2464.
    >> Share

  192. KUEHN BM
    Influenza Vaccination Increased During the COVID-19 Pandemic.
    JAMA. 2021;326:2465.
    >> Share

  193. ABBASI J
    Omicron Has Reached the US-Here's What Infectious Disease Experts Know About the Variant.
    JAMA. 2021;326:2460-2462.
    >> Share

  194. LAM DL, Flanagan MR
    Axillary Lymphadenopathy After COVID-19 Vaccination in a Woman With Breast Cancer.
    JAMA. 2021 Dec 23. pii: 2787650. doi: 10.1001/jama.2021.20010.
    >> Share

  195. DEL RIO C, Omer SB, Malani PN
    Winter of Omicron-The Evolving COVID-19 Pandemic.
    JAMA. 2021 Dec 22. pii: 2787609. doi: 10.1001/jama.2021.24315.
    >> Share

  196. KUEHN BM
    Vaccination Doesn't Eliminate Delta Variant Household Transmission.
    JAMA. 2021;326:2353.
    >> Share

  197. COHN AC, Mahon BE, Walensky RP
    One Year of COVID-19 Vaccines: A Shot of Hope, a Dose of Reality.
    JAMA. 2021 Dec 21. pii: 2787504. doi: 10.1001/jama.2021.23962.
    >> Share

  198. LEVY M, Recher M, Hubert H, Javouhey E, et al
    Multisystem Inflammatory Syndrome in Children by COVID-19 Vaccination Status of Adolescents in France.
    JAMA. 2021 Dec 20. pii: 2787495. doi: 10.1001/jama.2021.23262.
    >> Share

  199. ADAMS LE, Waterman S, Paz-Bailey G
    Vaccination for Dengue Prevention.
    JAMA. 2021 Dec 16. pii: 2787445. doi: 10.1001/jama.2021.23466.
    >> Share

  200. BATES TA, McBride SK, Winders B, Schoen D, et al
    Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough Infection.
    JAMA. 2021 Dec 16. pii: 2787447. doi: 10.1001/jama.2021.22898.
    >> Share

  201. SURAN M
    Why Parents Still Hesitate to Vaccinate Their Children Against COVID-19.
    JAMA. 2021 Dec 15. pii: 2787289. doi: 10.1001/jama.2021.21625.
    >> Share

  202. ABBASI J
    COVID-19 Vaccine Combination Was Superior in Real-world Study.
    JAMA. 2021;326:2250.
    >> Share

  203. WALTER K
    COVID-19 and Pregnancy.
    JAMA. 2021 Dec 10. pii: 2787240. doi: 10.1001/jama.2021.22679.
    >> Share


  204. Current Comment.
    JAMA. 2021;326:2217.
    >> Share

  205. GRUNAU B, Goldfarb DM, Asamoah-Boaheng M, Golding L, et al
    Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals.
    JAMA. 2021 Dec 3. pii: 2786992. doi: 10.1001/jama.2021.21921.
    >> Share

  206. ABBASI J
    Data Emerge From the UK's COVID-19 Vaccine Extended Dosing Interval.
    JAMA. 2021 Dec 3. pii: 2786993. doi: 10.1001/jama.2021.21963.
    >> Share

  207. FERNANDES B, Navin MC, Reiss DR, Omer SB, et al
    US State-Level Legal Interventions Related to COVID-19 Vaccine Mandates.
    JAMA. 2021 Dec 2. pii: 2786984. doi: 10.1001/jama.2021.22122.
    >> Share

    November 2021
  208. RUBIN R
    COVID-19 Vaccine Makers Plan for Annual Boosters, but It's Not Clear They'll Be Needed.
    JAMA. 2021 Nov 24. pii: 2786818. doi: 10.1001/jama.2021.21291.
    >> Share

  209. RUBIN R
    Substance Use Disorders and COVID-19 Vaccine Response.
    JAMA. 2021;326:2000.
    >> Share

  210. KUEHN BM
    COVID-19 Vaccine Highly Effective Against Adolescent Hospitalizations.
    JAMA. 2021;326:2002.
    >> Share

  211. KUEHN BM
    Unhygienic Practices Lead to Routine Vaccination-Linked Infections.
    JAMA. 2021;326:2002.
    >> Share

  212. JABAGI MJ, Botton J, Bertrand M, Weill A, et al
    Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older.
    JAMA. 2021 Nov 22. pii: 2786667. doi: 10.1001/jama.2021.21699.
    >> Share

  213. SFEIR MM, Snayd M
    Serologic Testing for Hepatitis B.
    JAMA. 2021 Nov 19. pii: 2786654. doi: 10.1001/jama.2021.19803.
    >> Share

  214. CHOR J, Davis AM, Rusiecki JM
    Cervical Cancer Screening Guideline for Individuals at Average Risk.
    JAMA. 2021 Nov 12. pii: 2786400. doi: 10.1001/jama.2021.13448.
    >> Share

  215. ABBASI J
    Flu Vaccine Candidate Elicits Enhanced Immune Response.
    JAMA. 2021;326:1784.
    >> Share

  216. ABBASI J
    Pfizer Launches Phase 1 mRNA Flu Vaccine Trial.
    JAMA. 2021;326:1784.
    >> Share

  217. ABBASI J
    "Polymutant" Spike Points Way Toward More Durable COVID-19 Vaccine.
    JAMA. 2021;326:1784.
    >> Share


  218. Routine Smallpox Vaccination.
    JAMA. 2021;326:1876.
    >> Share

  219. ELIAKIM-RAZ N, Leibovici-Weisman Y, Stemmer A, Ness A, et al
    Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged >/=60 Years.
    JAMA. 2021 Nov 5. pii: 2786096. doi: 10.1001/jama.2021.19885.
    >> Share

  220. MOSS WJ, Gostin LO, Nuzzo JB
    Pediatric COVID-19 Vaccines: What Parents, Practitioners, and Policy Makers Need to Know.
    JAMA. 2021 Nov 5. pii: 2786095. doi: 10.1001/jama.2021.20734.
    >> Share

  221. KLOMPAS M
    Understanding Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination.
    JAMA. 2021 Nov 4. pii: 2786040. doi: 10.1001/jama.2021.19063.
    >> Share

  222. TENFORDE MW, Self WH, Adams K, Gaglani M, et al
    Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
    JAMA. 2021 Nov 4. pii: 2786039. doi: 10.1001/jama.2021.19499.
    >> Share

  223. CROWE EH
    The Taste of Hope.
    JAMA. 2021;326:1683-1684.
    >> Share

  224. ZHONG D, Xiao S, Debes AK, Egbert ER, et al
    Durability of Antibody Levels After Vaccination With mRNA SARS-CoV-2 Vaccine in Individuals With or Without Prior Infection.
    JAMA. 2021 Nov 1. pii: 2785919. doi: 10.1001/jama.2021.19996.
    >> Share

  225. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, Yassine HM, et al
    Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar.
    JAMA. 2021 Nov 1. pii: 2785918. doi: 10.1001/jama.2021.19623.
    >> Share

    October 2021
  226. ABBASI J
    The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity.
    JAMA. 2021 Oct 21. pii: 2785530. doi: 10.1001/jama.2021.18919.
    >> Share

  227. RUBIN R
    Trying to Block SARS-CoV-2 Transmission With Intranasal Vaccines.
    JAMA. 2021 Oct 14. pii: 2785303. doi: 10.1001/jama.2021.18143.
    >> Share

  228. SZILAGYI PG, Thomas K, Shah MD, Vizueta N, et al
    Changes in COVID-19 Vaccine Intent From April/May to June/July 2021.
    JAMA. 2021 Oct 13. pii: 2785290. doi: 10.1001/jama.2021.18761.
    >> Share

  229. ABBASI J
    India's New COVID-19 DNA Vaccine for Adolescents and Adults Is a First.
    JAMA. 2021;326:1365.
    >> Share

  230. ABBASI J
    Moderna's mRNA Vaccine for Seasonal Flu Enters Clinical Trials.
    JAMA. 2021;326:1365.
    >> Share

  231. ABBASI J
    Vaccine-Induced SARS-CoV-2 Antibodies in Inflammatory Diseases.
    JAMA. 2021;326:1365.
    >> Share

  232. KUEHN BM
    HPV Vaccination Coverage Has Increased Among Adolescents.
    JAMA. 2021;326:1366.
    >> Share

  233. WOO EJ, Mba-Jonas A, Dimova RB, Alimchandani M, et al
    Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barre Syndrome, February-July 2021.
    JAMA. 2021 Oct 7. pii: 2785009. doi: 10.1001/jama.2021.16496.
    >> Share

    September 2021
  234. RUBIN R
    COVID-19 Vaccine Nasal Spray.
    JAMA. 2021;326:1138.
    >> Share

  235. KRONMAL SL
    Shots in Arms.
    JAMA. 2021;326:1151-1152.
    >> Share

    August 2021
  236. RUBIN R
    Influenza's Unprecedented Low Profile During COVID-19 Pandemic Leaves Experts Wondering What This Flu Season Has in Store.
    JAMA. 2021 Aug 25. pii: 2783644. doi: 10.1001/jama.2021.14131.
    >> Share

  237. DETSKY AS, Bogoch II
    COVID-19 in Canada: Experience and Response to Waves 2 and 3.
    JAMA. 2021 Aug 23. pii: 2783610. doi: 10.1001/jama.2021.14797.
    >> Share

  238. DEL RIO C, Malani PN, Omer SB
    Confronting the Delta Variant of SARS-CoV-2, Summer 2021.
    JAMA. 2021 Aug 18. pii: 2783478. doi: 10.1001/jama.2021.14811.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016